Skip to main content
PepStack
Blutwerte · Marker

GGT

Gamma-Glutamyltransferase · Gamma-GT · GGT

Leberwerte
Einheit:
IU/L

GGT measures the activity of the gamma-glutamyltransferase enzyme, which is involved in glutathione metabolism and liver function.

Reference Ranges

Reference
060IU/L
0
10
40
60
LowNormalHigh
Reference
Optimal
Unit · IU/L

Reference ranges may vary slightly by laboratory and consider sex-specific differences.

Overview

Übersicht

Gamma-glutamyltransferase (GGT) is an enzyme found predominantly in the liver, playing a crucial role in the gamma-glutamyl cycle, which is essential for the synthesis and degradation of glutathione, a major antioxidant. Clinically, GGT is a significant marker for liver function and is often elevated in cases of liver disease, alcohol abuse, and biliary obstruction. It is also associated with cardiovascular disease, diabetes, metabolic syndrome, and increased mortality risk. In the context of athletic performance and biohacking, GGT levels can indicate oxidative stress and liver health, which are critical for recovery and overall metabolic efficiency. However, researchers observed that GGT levels can be influenced by factors such as age, gender, alcohol consumption, and obesity. Therefore, it is important to consider these variables when interpreting GGT levels. Additionally, fasting and time of day do not significantly affect GGT measurements, but recent alcohol intake or liver-affecting medications can skew results.

Klinische Bedeutung

Elevated GGT levels indicate liver dysfunction, alcohol abuse, or biliary obstruction. Low GGT levels are uncommon and typically not clinically significant.

Dynamics

Trend Interpretation

Rising Values

Progressively rising GGT values suggest worsening liver function or increased alcohol intake. Retest in 4 weeks if elevated.

Falling Values

Falling GGT values indicate improvement in liver function or reduction in alcohol consumption.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Alcohol abuse
  • Liver disease
  • Biliary obstruction
  • Heart failure
  • Metabolic syndrome
Cause

Low Levels

  • Not clinically significant
  • Rare genetic conditions
  • Certain medications
  • Malnutrition
Protocol

How to Optimize

Lever

Lifestyle

  • Reduce alcohol consumption
  • Maintain a healthy weight
  • Engage in regular physical activity
Lever

Nutrition

  • Increase antioxidant-rich foods
  • Consume a balanced diet
  • Limit processed foods
Lever

Supplementation

  • Milk thistle
  • N-acetylcysteine
  • Alpha-lipoic acid

Note:

Consult a healthcare provider before starting any supplementation, especially if liver disease is present.

Testing Guidelines

Fasting Not Required
Not Time-Sensitive

GGT levels may vary with diurnal rhythms; consistency in testing time is recommended.

Testing Frequency

Annually for healthy adults, more frequently if liver disease is suspected.

Interfering Factors

  • Recent alcohol consumption
  • Certain medications
  • Liver disease

Open Research Questions

Current research suggests that the reference intervals for GGT may need to be revisited, particularly concerning confounders like gender, age, and obesity. Researchers have not yet established optimal GGT targets for predicting disease risk across diverse populations. Additionally, clinical questions remain unanswered regarding the specific mechanisms linking GGT to various diseases and the potential utility of GGT in risk stratification for conditions beyond liver disease.

19 Research Publications

419

Total Citations

6

Human/RCT

3.3

Avg. Influence

2018

Latest

Sort
Filter
#01

Alcohol Biomarkers in Clinical and Forensic Contexts.

ReviewInfluence7.0
154
Researchers reviewed various biomarkers of alcohol consumption and highlighted GGT as a key indirect marker. They noted that GGT, along with carbohydrate-deficient transferrin (CDT), is crucial for verifying alcohol abstinence and ruling out harmful alcohol use. The study emphasizes the importance of selecting appropriate markers based on specific clinical questions.
View on PubMed
#02

The dark side of gamma-glutamyltransferase (GGT): Pathogenic effects of an 'antioxidant' enzyme.

ReviewInfluence3.0
100
Researchers reviewed the role of GGT in human pathophysiology and found that it may have pathogenic effects beyond its traditional role as an antioxidant. They noted that GGT is involved in the modulation of redox equilibria and is linked to various diseases, including cardiovascular diseases and cancer. This suggests a need to reevaluate GGT's significance in health and disease.
View on PubMed
#03

gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk.

ReviewInfluence2.0
60
Researchers examined the role of gamma-glutamyltransferase (GGT) as a potential biomarker for cardiovascular risk. They found that elevated serum GGT levels may indicate a higher risk for cardiovascular events, suggesting its utility in primary and secondary prevention strategies. The study calls for further research to confirm these findings.
View on PubMed
#04

A Systematic Review of Serum γ-Glutamyltransferase as a Prognostic Biomarker in Patients with Genitourinary Cancer.

Meta-AnalysisInfluence1.0
53
This systematic review assessed the prognostic role of serum gamma-glutamyltransferase (GGT) in patients with genitourinary cancers. Researchers found that elevated GGT levels are associated with an increased risk of cancer progression and poor prognosis, highlighting its potential as a biomarker for monitoring these patients.
View on PubMed
#05

Serum Gamma-glutamyltransferase and Obesity: is there a Link?

Human
28
Researchers found a significant association between increased GGT levels and unfavorable body fat distribution in healthy individuals. The study indicated that higher GGT levels correlate with increased android fat and a higher android/gynoid fat ratio. This suggests that GGT may serve as an early biomarker for assessing body fat distribution.
View on PubMed
#06

Advances and Perspectives of Responsive Probes for Measuring γ-Glutamyl Transpeptidase.

Review
12
Researchers reviewed recent advances in measuring gamma-glutamyltransferase (GGT) activity using responsive probes. They highlighted various bioanalytical methods for GGT measurement and discussed the practical applications of these probes in cancer diagnosis and treatment monitoring, emphasizing the importance of GGT as a biomarker in clinical settings.
View on PubMed
#07

Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma?

Human
7
This study evaluated the diagnostic potential of gamma-glutamyltransferase (GGT) sub-fractions in malignant pleural mesothelioma (MPM). Researchers identified specific GGT activity patterns associated with MPM, suggesting that these fractions could enhance diagnostic accuracy when combined with other biomarkers. The findings support the potential of GGT in cancer diagnostics.
View on PubMed
#08

Serum Gamma Glutamyltransferase: A Biomarker for Identifying Postprandial Hypertriglyceridemia.

Human
4
Researchers found that elevated serum GGT levels are significantly associated with postprandial hypertriglyceridemia (PHTG). The study indicated that GGT serves as an effective predictor of PHTG risk, highlighting its role in identifying individuals at risk for metabolic disturbances. This suggests that GGT could be a valuable biomarker in metabolic assessments.
View on PubMed
#09

Gamma-glutamyltransferase independently predicts mortality and heart failure hospitalization in cardiac transthyretin amyloidosis.

Human
1
Researchers found that elevated GGT levels are associated with greater disease severity and predict worse outcomes in patients with transthyretin cardiac amyloidosis. The study showed that GGT remains a significant predictor of all-cause mortality and heart failure hospitalization. This suggests that GGT measurement may enhance risk stratification in affected individuals.
View on PubMed
#10

Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk.

Review
Researchers observed that elevated GGT levels are linked to an increased risk of various diseases, including cardiovascular disease and diabetes. They noted that GGT serves as a predictive marker for several health conditions and has shown a rising trend in population levels over time. The study emphasizes GGT's role in indicating future disease risk.
View on PubMed

Publication Trend

Research publications about GGT over time

9total
1
'06
2
'18
1
'20
1
'21
1
'22
1
'23
1
'24
1
'25

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer